CMFRI, Library (2017) CMFRI develops anti-obesity nutraceutical The Hindu dated 28th May 2017. The Hindu.
|
Text
The Hindu_28 May 2017.pdf Download (101kB) | Preview |
Official URL: http://www.thehindu.com/news/cities/Kochi/cmfri-de...
Related URLs:
Abstract
The anti-obesity nutraceutical developed by the Central Marine Fisheries Research Institute (CMFRI) from seaweeds will soon hit the market. The CMFRI has signed a pact with healthcare group VLCC for the commercial production of the product named Cadalmin Antihypercholesterolemic extract (Cadalmin - ACe), a natural remedy for obesity. A. Gopalakrishnan, director of CMFRI, signed a licence agreement with the director and executive vice president of the firm, said a release. Cadalmin was developed using natural marine bioactive ingredients from selected seaweeds.
| Item Type: | Other |
|---|---|
| Uncontrolled Keywords: | Newspaper; News; CMFRI in Media |
| Subjects: | Library & Information Science CMFRI News Clippings |
| Divisions: | Library and Documentation Centre |
| Depositing User: | Arun Surendran |
| Date Deposited: | 05 Jun 2017 09:49 |
| Last Modified: | 05 Jun 2017 09:49 |
| URI: | http://eprints.cmfri.org.in/id/eprint/11918 |
Actions (login required)
 |
View Item |
